Back to search
FDAFDA · Food and drugs·Recall number D-1333-2022

SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519-0204 Miami 33172 FL, USA; UPC 0 705632 523285

Published August 10, 2022 · Recall initiated: July 22, 2022

Summary

FDA records drug Class I recall D-1333-2022, published August 10, 2022 and initiated July 22, 2022. Recalling firm: Distributor RFR, LLC.; Status: Terminated; Reported quantity: 2000 cartons; Lot: Lot: 48656, Exp. 01/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Distributor RFR, LLC.
Distributor
Retail stores in the state of FL, Nationwide in the USA, France and Canada via website sales, and Bolivarian Republic of Venezuela
Lot
Lot: 48656, Exp. 01/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519-0204 Miami 33172 FL, USA; UPC 0 705632 523285 recalled?

Yes. FDA published recall D-1333-2022 on August 10, 2022. Reported hazard: Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.

What should I do if I have this product?

Voluntary: Firm initiated · Letter